Navigation
Recherche
|
GLP-1 Drug Use Surges 600% as 2% of Americans Take Weight-Loss Medications
mardi 27 mai 2025, 18:40 , par Slashdot
![]() In all, roughly 4% of Americans were taking GLP-1 drugs in 2024 for either overweight, obesity or Type 2 diabetes (their original approved use). The data shows Novo Nordisk's Ozempic is still by far the most commonly taken GLP-1, followed by Eli Lilly's Mounjaro. The percentage of adults who were prescribed a GLP-1 drug but did not have bariatric surgery increased from 2.5% in 2019 to 11.2% in 2024 while the the percentage of adult patients who had bariatric surgery decreased 41.8%. Read more of this story at Slashdot.
https://science.slashdot.org/story/25/05/27/1633220/glp-1-drug-use-surges-600-as-2-of-americans-take...
Voir aussi |
56 sources (32 en français)
Date Actuelle
dim. 1 juin - 12:27 CEST
|